Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate |
2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1faef07d3929baf9f3c61717305c662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76cf51596980f303b11751137945fe15 |
publicationDate |
2008-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1967181-A1 |
titleOfInvention |
Pharmaceutical formulation comprising a CB1-Receptor compound in a solid solution and/or solid dispersion |
abstract |
The present invention relates to a pharmaceutical formulation comprising 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide as racemate or (R)- and (S)-enantiomer or mixtures thereof in a solid solution and/or solid dispersion. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3120871-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231929-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106232144-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106232144-B |
priorityDate |
2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |